# Isavuconazole in Critically Ill Patients: Efficacy and Safety

> **NCT07080359** · — · NOT_YET_RECRUITING · sponsor: **Shanghai 10th People's Hospital** · enrollment: 75 (estimated)

## Conditions studied

- Fungal Infection
- Aspergillosis
- Mucormycosis

## Interventions

- **DRUG:** Isavuconazole treatment

## Key facts

- **NCT ID:** NCT07080359
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07080359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07080359, "Isavuconazole in Critically Ill Patients: Efficacy and Safety". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07080359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*